Skip Navigation
Skip Website Tools

Contact Info

Beth Spinelli (Interventional Agents)
Project Officer, Drug Development Section
Office of Biodefense Research Affairs

Raymond Harris (Biopharmaceutical Products)
Program Officer
Office of Biodefense Research Affairs

Microbiology and Infectious Diseases Resources

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Therapeutic Development Services

The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins, including

  • Interventional Agents—therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents.
  • Biopharmaceutical Products—therapeutics that are derived from biotechnology processes, such as monoclonal antibodies and derivatives of monoclonal antibodies; recombinant proteins; peptides; nucleic acid based vectors (siRNA, plasmids); and live, modified-live and/or attenuated entities.

Last Updated March 05, 2014